Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126643051 | 12664305 | 1 | I | 2016 | 20160804 | 20160818 | 20160818 | EXP | CA-HQ SPECIALTY-CA-2016INT000778 | INTERCHEM | 51.00 | YR | F | Y | 0.00000 | 20160818 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126643051 | 12664305 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 1.4286 MG (10 MG,1 IN 1 W) | 201749 | 10 | MG | ||||||||
| 126643051 | 12664305 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | Oral | 2.1429 MG (15 MG,1 IN 1 W) | 201749 | 15 | MG | ||||||||
| 126643051 | 12664305 | 3 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG (5 MG,2 IN 1 D) | 0 | 5 | MG | ||||||||
| 126643051 | 12664305 | 4 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG (5 MG,2 IN 1 D) | 0 | 5 | MG | ||||||||
| 126643051 | 12664305 | 5 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG (5 MG,2 IN 1 D) | 0 | 5 | MG | ||||||||
| 126643051 | 12664305 | 6 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 10 MG (5 MG,2 IN 1 D) | 0 | 5 | MG | ||||||||
| 126643051 | 12664305 | 7 | SS | METHOTREXATE. | METHOTREXATE | 1 | Subcutaneous | 2.8571 MG (20 MG,1 IN 1 W) | 0 | 20 | MG | ||||||||
| 126643051 | 12664305 | 8 | SS | CELEBREX | CELECOXIB | 1 | Unknown | UNK | 0 | ||||||||||
| 126643051 | 12664305 | 9 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126643051 | 12664305 | 1 | Rheumatoid arthritis |
| 126643051 | 12664305 | 3 | Rheumatoid arthritis |
| 126643051 | 12664305 | 7 | Rheumatoid arthritis |
| 126643051 | 12664305 | 8 | Rheumatoid arthritis |
| 126643051 | 12664305 | 9 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126643051 | 12664305 | HO |
| 126643051 | 12664305 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126643051 | 12664305 | Lung infection | |
| 126643051 | 12664305 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126643051 | 12664305 | 1 | 201605 | 0 | ||
| 126643051 | 12664305 | 3 | 20151030 | 201511 | 0 | |
| 126643051 | 12664305 | 4 | 20151125 | 201601 | 0 | |
| 126643051 | 12664305 | 5 | 20160215 | 20160229 | 0 | |
| 126643051 | 12664305 | 6 | 20160323 | 20160628 | 0 | |
| 126643051 | 12664305 | 7 | 201509 | 0 |